Warsaw-based Doctor.One, a medtech developing its virtual clinic solution has raised €1 million in a funding round led by a Polish Smartlink Partners. The Ukrainian Vesna Capital also joined the investment. The fresh costs will be used for development, including integration of solutions that automate the doctor’s work.
- Doctor.One was established in 2021 by Tomasz Rudolf and Maciej Malenda. It develops an application, a secure medical messenger replacing informal communication via text messages, e-mails and social media, allowing doctors to be in contact only with their regular patients whom they know from stationary visits. The startup claims that application also enables doctors to organize communication with patients, and gives patients the opportunity to contact the doctor and get help, remunerating the doctor in a subscription model.
- In May 2022, Doctor.One secured a €2.1 million in funding led by Atlantic Labs. Earlier, in 2021 the startup raised a €440,000 pre-seed investment from Movens Capital.
- The fresh round was led by Smartlink Partners, a Warsaw-based venture capital fund that invests in early-stage e-commerce, fintech, AI and ML, medtech, and hardware startups. The fund’s average ticket size ranges from €433,000 to €1,733 million (PLN 2 million to PLN 8 million). It’s most recent investment was HRtech OstendiHR which secured €433,000 in October 2023.
- Smartlink Partners is currently joining the company using the CLA instrument (convertible loan) with a commitment of €500,000. In addition to Smartlink Partners, the company is also joined by the Vesna Capital, an investment fund created by Andriy Fedoriv, Viacheslav Klymov, and Volodymyr Popereshniuk.
The fresh round will help Doctor.One intends to introduce further software features, such as: care teams (the ability to manage the patient by a group of specialists), integration with external systems and diagnostic service providers, as well as the introduction of elements of artificial intelligence and automation to support doctors in more effective patient support.